Gilbert 2017.
Study characteristics | ||
Methods | Design: Randomized controlled trial Setting: General practices in England, UK Recruitment: People who were currently smoking were identified from medical records in participating practices and sent an invitation letter |
|
Participants | 4384 adults who smoked, 50% M, av. age 49, av. cpd 16 99 general practices in 18 Stop Smoking Service areas |
|
Interventions | Intervention: participants received a brief personalized and tailored letter sent from the GP that included information specific to the participant and a personal invitation to attend a “come and try it” taster session for cessation services Control: participants received a standard generic letter from the GP practice, which advertised the local SSS and asked the participant to contact the service to make an appointment to see an adviser |
|
Outcomes | 3m prolonged abstinence at 6m Validation: Salivary cotinine level < 12 ng/mL Quit attempts |
|
Funding Source | This study was funded by the National Institute for Health Research Health Technology Assessment Programme (project number 08/58/02). | |
Author's declarations of interest | QUOTE: "Irwin Nazareth is a member of the National Institute for Health Research Health Technology Assessment Funding Commissioning Panel. | |
Notes | Strategy: Tailored materials Level: Patients Comparison type: Single component vs. standard care |
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Sequence Generation | Low risk | Computer‐generated permutated block randomization |
Allocation concealment | Low risk | Allocated by computer after participant consented |
Blinding of outcome assessors All outcomes | Low risk | Abstinence was biochemically validated. Participant contact was minimal in both groups. |
Incomplete outcome data All outcomes | Low risk | The overall loss to follow‐up was 23.1% (n = 1012/4384); 23.4% (n = 616/2636) in the intervention group and 22.7% (n = 396/1748) in the control group were lost to follow‐up at 6 months |